Head-to-Head

Ginkgo Bioworks Holdings, Inc. vs. Repligen Corp

DNA

Ginkgo Bioworks Holdings, Inc.

$8.44 +1.44%

VS RGEN

Repligen Corp

$170.29 -1.38%

Repligen Corp (RGEN) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

DNARGEN
Market Cap $539.34 million $11.04 billion

RGEN leads on 1 of 1 size & scale factors.

Risk & Sentiment

DNARGEN
Short Interest 19.24% 6.30%

RGEN leads on 1 of 1 risk & sentiment factors.

Dig deeper: DNA overview, DNA financials, RGEN overview, RGEN financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.